NO902491L - Proteiner, vaksiner og nukleinsyrer. - Google Patents

Proteiner, vaksiner og nukleinsyrer.

Info

Publication number
NO902491L
NO902491L NO90902491A NO902491A NO902491L NO 902491 L NO902491 L NO 902491L NO 90902491 A NO90902491 A NO 90902491A NO 902491 A NO902491 A NO 902491A NO 902491 L NO902491 L NO 902491L
Authority
NO
Norway
Prior art keywords
proteins
vaccines
nucleic acids
protein
production
Prior art date
Application number
NO90902491A
Other languages
English (en)
Norwegian (no)
Other versions
NO902491D0 (no
Inventor
Franz X Heinz
Christian W Mandl
Christian Kunz
Friedrich Dorner
Walter Bodemer
Gerhard Antoine
Original Assignee
Immuno Aktienges Fuer Chemisch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Aktienges Fuer Chemisch filed Critical Immuno Aktienges Fuer Chemisch
Publication of NO902491D0 publication Critical patent/NO902491D0/no
Publication of NO902491L publication Critical patent/NO902491L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO90902491A 1989-06-06 1990-06-05 Proteiner, vaksiner og nukleinsyrer. NO902491L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89305708 1989-06-06

Publications (2)

Publication Number Publication Date
NO902491D0 NO902491D0 (no) 1990-06-05
NO902491L true NO902491L (no) 1990-12-07

Family

ID=8202711

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902491A NO902491L (no) 1989-06-06 1990-06-05 Proteiner, vaksiner og nukleinsyrer.

Country Status (12)

Country Link
EP (1) EP0402116B1 (fr)
JP (1) JPH03151878A (fr)
AT (1) ATE143373T1 (fr)
CA (1) CA2018332A1 (fr)
CZ (1) CZ277921B6 (fr)
DD (1) DD297997A5 (fr)
DE (1) DE69028658T2 (fr)
FI (1) FI902814A7 (fr)
HU (1) HUT54306A (fr)
NO (1) NO902491L (fr)
SK (1) SK277781B6 (fr)
YU (1) YU109590A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4224402A1 (de) * 1992-07-21 1994-01-27 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
DE4426622C1 (de) * 1994-07-27 1996-02-22 Immuno Ag Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben
FR2794865B1 (fr) * 1999-06-09 2003-04-18 Pasteur Institut Methode de detection precoce des flavivirus et ses applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284791B1 (fr) * 1987-03-20 1995-05-03 IMMUNO Aktiengesellschaft Molécules d'ADN et d'ARN du virus de la méningoencéphalite du printemps précoce sous-type de l'ouest, polypeptides codés par celles-ci ainsi que leur utilisation
IL91304A0 (en) * 1988-08-20 1990-03-19 Us Health Recombinant vaccinia virus for prevention of disease caused by flavivirus

Also Published As

Publication number Publication date
FI902814A7 (fi) 1990-12-07
EP0402116A1 (fr) 1990-12-12
CZ277921B6 (en) 1993-06-16
CS9002806A2 (en) 1991-11-12
SK277781B6 (en) 1995-01-12
NO902491D0 (no) 1990-06-05
DE69028658T2 (de) 1997-03-06
CA2018332A1 (fr) 1990-12-06
DD297997A5 (de) 1992-01-30
HU903490D0 (en) 1990-10-28
JPH03151878A (ja) 1991-06-28
FI902814A0 (fi) 1990-06-05
EP0402116B1 (fr) 1996-09-25
YU109590A (sh) 1992-07-20
DE69028658D1 (de) 1996-10-31
ATE143373T1 (de) 1996-10-15
HUT54306A (en) 1991-02-28

Similar Documents

Publication Publication Date Title
DK84194A (da) Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
ATE61228T1 (de) Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff.
UA42668C2 (uk) Поліпептид, що має антигенні властивості вірусу гепатиту с (hcv) (варіанти), діагностичний реагент для виявлення антитіл до вірусу гепатиту с (варіанти), набір для виявлення антитіл до вірусу гепатиту с (варіанти), спосіб виявлення антитіл до вірусу гепатиту с (варіанти)
BR8701528A (pt) Proteina,sequencia de dna,vetor recombinante,organismo celular,processos para producao de uma proteina e para a preparacao de um organismo unicelular,processos para a deteccao da presenca de anticorpos e de virus de aids,processos para a preparacao de uma vacina e para a preparacao de anticorpos,formulacao de vacina,anticorpos,uso,vacina,kit de teste e metodo para a prevencao de aids
BR9608615A (pt) Vacinas de vírus sincicial respiratório de ácido nucléico
DK0754704T3 (da) Syntetiske antigener til påvisning af antistoffer mod hepatitis c-virus
ATE36956T1 (de) Verfahren zu herstellung von lebenden, adjuvierten impfstoffen und so erhaltende lebende, adjuvierte impfstoffe.
DK11187D0 (da) Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem
NO902491L (no) Proteiner, vaksiner og nukleinsyrer.
DK0495907T3 (da) cDNA-fragment, som koder for alfa-interferon-receptorgenet, og fremgangsmåde til fremstilling af et tilsvarende protein
WO1990012807A3 (fr) Procede et anticorps purifies a specificite elevee contre des produits genetiques, y compris des retinoblastomes
DK589586A (da) Ekspression og diagnostisk anvendelse af gag-kodede peptider, der er immunologisk reaktive med antistoffer til lav.
JPS642586A (en) Western subtype dna and rna molecule of fsme-virus, polypeptide coded by the molecule and its usage
DE69021879D1 (de) Verfahren zur herstellung von impfstoffen gegen rna-virus.
HUP9900766A2 (hu) Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez
TH4148A (th) Dna ชนิดใหม่และโพลิเพนไทด์
ES8801959A1 (es) Un procedimiento para ensayos de sangre humana respecto de la presencia de anticuerpos frente al agente etiologico viral de sida